Europe PMC
open access
Why CD4+ T cells matter in adoptive cell therapy for solid cancers
Cytotoxic CD8+ T cells have been the focus of research efforts to improve the efficacy of anticancer adoptive cell therapies. However, emerging evidence is highlighting the critical role of CD4+ T cells in these treatments, including chimeric antigen receptor-T cells. Although the presence of CD4+ T
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Model-based integration of chimeric antigen receptor T-cell kinetics and tumor features to predict therapeutic outcomes in patients with B-cell malignancies.#1373906
- DEVELOPING ADOPTIVE T CELL STRATEGIES FOR CANINE CANCERS#637515
- Adoptive Therapy Using Antigen-Specific CD4 T-Cells#373597
- Expression of a chimeric antigen receptor in multiple leukocyte lineages in transgenic mice#1005204
- Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHL#1363648
Record · ID 1218620
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive